Cargando…
Ustekinumab Tissue and Serum Levels in Patients With Crohn’s Disease Are Closely Correlated Though Not Consistently Associated With Objective Response After Induction
BACKGROUND: Ustekinumab (UST), which targets p40/interleukin (IL)-23 and IL-12, is an effective treatment for Crohn’s disease (CD). Therapeutic drug monitoring may optimize UST posology. The aim of this study was to investigate UST and IL-23 serum and tissue concentrations in relation to mucosal inf...
Autores principales: | Proietti, Elisa, Pauwels, Renske W M, van der Woude, Christien J, Doukas, Michael, Oudijk, Lindsey, Peppelenbosch, Maikel P, Grohmann, Ursula, Crombag, Marie-Rose B S, de Vries, Annemarie C, Fuhler, Gwenny M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320373/ https://www.ncbi.nlm.nih.gov/pubmed/35917118 http://dx.doi.org/10.1093/ibd/izac169 |
Ejemplares similares
-
Vedolizumab Tissue Concentration Correlates to Mucosal Inflammation and Objective Treatment Response in Inflammatory Bowel Disease
por: Pauwels, Renske W M, et al.
Publicado: (2021) -
Modulation of Indoleamine 2,3-Dioxygenase 1 During Inflammatory Bowel Disease Activity in Humans and Mice
por: Proietti, Elisa, et al.
Publicado: (2023) -
Peripheral Neutrophil Functions and Cell Signalling in Crohn`s Disease
por: Somasundaram, Rajesh, et al.
Publicado: (2013) -
Cannabinoid Signal Transduction Explains Disconnect of Cannabis Effects in Experimental and Clinical Colitis
por: Peppelenbosch, Maikel P, et al.
Publicado: (2019) -
A Direct Effect of Sex Hormones on Epithelial Barrier Function in Inflammatory Bowel Disease Models
por: van der Giessen, Janine, et al.
Publicado: (2019)